Latest Breaking News On - Investors general - Page 1 : vimarsana.com

Aelis Farma: Combined General Meeting of June 4, 2024: Availability of Preparatory Documents and Participation and Voting Procedures

Aelis Farma: Combined General Meeting of June 4, 2024: Availability of Preparatory Documents and Participation and Voting Procedures
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNeurocentre magendieArthur rouillDaelis farmaVincenzo piazzaCorporate developmentRegulatory newsCombined general meetingLafaurie de mondabonGeneral meetingInvestors generalCommercial codePier vincenzo piazzaDown syndromeEuronext parisUniversal registration document

Aelis Farma: Combined General Meeting of May 24, 2023: Availability of Preparatory Documents and Participation and Voting Procedures

Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, informs

United statesFrance generalVincenzo piazzaMagendie neurocenterDaelis farmaArthur rouillCombined general meetingLafaurie de mondabonGeneral meetingInvestors generalCommercial codeSignaling specificPier vincenzo piazzaDown syndromeEuronext parisUniversal registration document

Aelis Farma: Ordinary General Meeting of June 28, 2022: Availability of Preparatory Documents and Participation and Voting Procedures

Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the Company »),

United statesNicolas merigeauVincenzo piazzaInserm magendie neurocentreDaelis farmaAlbert marquetInserm transfert initiativeCentre broca nouvelle aquitaineNeurology of the french academy sciencesRegulatory newsOrdinary general meetingGeneral meetingInvestors generalCommercial codeSignaling specificPier vincenzo piazza

Transgene s Combined General Meeting of May 25, 2022

Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard

United statesIllkirch graffenstadenRheinland pfalzLucie larguierSandrine floryBen brahimAlessandro rivaMarie landelSylvie berrebiLaurence espinassePhilippe archinardTransgene euronextCentre sud montpellierEuropean society of medical oncologyEuropean commission conticanetClaude bernard university in lyon

Genomic Vision Announces the Approval by Its Shareholders Meeting of All the Resolutions Supported by the Executive Board

Regulatory News: Genomic Vision(FR0011799907 GV the "Company"), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, informs its

France generalDominique remy renouStrategic communicationsRegulatory newsExtraordinary shareholder meetingDes meuniersInvestors generalGenomic vision